Detalhe da pesquisa
1.
Cross-Protection Induced by Highly Conserved Human B, CD4+, and CD8+ T Cell Epitopes-Based Coronavirus Vaccine Against Severe Infection, Disease, and Death Caused by Multiple SARS-CoV-2 Variants of Concern.
bioRxiv
; 2023 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292861